XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue
 6 Months Ended
Jun. 30, 2023
Revenue  
Revenue

Note 4. Revenue 

Product Net Sales


(in thousands)


Three months ended June 30,

Six months ended June 30,


Channel

2023


2022

2023


2022
Rx gammaCore - Department of Veteran Affairs and Department of Defense
$ 2,081

$ 1,190
$ 3,786

$ 2,430
Rx gammaCore - U.S. Commercial

441


465

871


741
Outside the United States

424


467

834


772
Truvaga

290


—

437


—
TAC-STIM

311


—

399


—
Other

4


35

4

113


$ 3,551

$ 2,157
$ 6,331

$ 4,056

Geographical Net Sales

The following table presents net sales disaggregated by geographic market:  


 


Three months ended June 30,
Six months ended June 30,

(in thousands)



2023


2022

2023


2022

Product revenue
















United States


$ 3,127

$ 1,690
$ 5,497
$ 3,284
United Kingdom

384


355

705


621
Other

22


64

65


103
License revenue














Japan

18


48

64


48

Total Net Sales


$ 3,551

$ 2,157
$ 6,331

$ 4,056

The Company generally invoices the customer and recognizes revenue once its performance obligations are satisfied, at which point payment is unconditional. Agreed upon payment terms with customers are within 30 days of shipment. Accordingly, contracts with customers do not include a significant financing component.